Aza

SELLAS Life Sciences announces agreement with IMPACT-AML to expand SLS009 clinical program into Europe, with US enrollment planned for Q1 [----] and European enrollment in Q2 [----].

About Aza

Aza is a decentralized digital currency and smart contract platform.

Insights

aza engagements is up 682.19% from the previous week.
aza posts created is up 977.74% from the previous week.
aza Creators hit a 52-Week high of [-----] for the day
aza Creators hit an all time of [-----] for the day
aza Mentions hit a 52-Week high of [-----] for the day
aza Mentions hit an all time of [-----] for the day

Engagements: [---------] (24h)

Engagements Line Chart
Engagements 24-Hour Time-Series Raw Data
Current Value: [---------]
Daily Average: [---------]
[--] Week: [----------] +682%
[--] Month: [-----------] +15%
[--] Months: [-------------] +6.20%
[--] Year: [-------------] +169%
1-Year High: [----------] on 2025-12-06
1-Year Low: [---------] on 2025-05-05

Engagements by network (24h): X: [---------] TikTok: [---------] YouTube: [---------] Reddit: [---] News: [---] Instagram: [-------]

Mentions: [-----] (24h)

Mentions Line Chart
Mentions 24-Hour Time-Series Raw Data
Current Value: [-----]
Daily Average: [-----]
1-Year High: [-----] on 2026-02-14
1-Year Low: [---] on 2025-03-15

Mentions by network (24h): X: [-----] TikTok: [---] YouTube: [-----] Reddit: [--] News: [--] Instagram: [--]

Creators: [-----] (24h)

Creators Line Chart
Creators 24-Hour Time-Series Raw Data
[-----] unique social accounts have posts mentioning Aza in the last [--] hours which is down 10% from [-----] in the previous [--] hours Daily Average: [-----]
1-Year High: [-----] on 2026-02-14
1-Year Low: [---] on 2025-03-15

The most influential creators that mention Aza in the last [--] hours

Creator	Rank	Followers	Posts	Engagements
@aza_guzmann	[--]	[-------]	[--]	[---------]
@aqeelaaz_	[--]	[---------]	[--]	[-------]
@john322226	[--]	[-------]	[--]	[-------]
@azacenel	[--]	[------]	[--]	[-------]
@tunemusicalmoments	[--]	[---------]	[--]	[-------]
@azanostalgia	[--]	[------]	[--]	[-------]
@anjumanazaehusainsurouli8105	[--]	[------]	[--]	[------]
@moon.lightpuri	[--]	[------]	[--]	[------]
@derya_arms	[--]	[-------]	[--]	[------]
@lattedolceice	[--]	[-----]	[--]	[------]

Sentiment: 74%

Sentiment Line Chart
Sentiment 24-Hour Time-Series Raw Data
Current Value: 74%
Daily Average: 71%
[--] Week: 66% +2%
[--] Month: 70% +5%
[--] Months: 70% -4%
[--] Year: 70% +3%
1-Year High: 96% on 2025-03-18
1-Year Low: 25% on 2025-04-16

Most Supportive Themes:

Community Engagement: (40%) Posts focusing on user interactions and discussions within the community.
Project Updates: (30%) Announcements and news related to the development and progress of the project.
Educational Content: (20%) Posts aimed at teaching users about the topic or its related technologies.

Most Critical Themes:

Security Concerns: (75.5%) Discussions and warnings about potential vulnerabilities or risks.
Market Volatility: (24.5%) Analysis and commentary on the fluctuating market value and its impact.

Top Aza News

Top news links shared on social in the last [--] hours

Showing a maximum of [--] news posts without a LunarCrush subscription.

"SELLAS Life Sciences Enters Agreement with IMPACT-AML to Expand SLS009 Clinical Program into Europe Supports capital-efficient expansion of the SLS009 clinical program into frontline AML enabling broader U.S. and European patient enrollment U.S. enrollment evaluating SLS009 in combination with AZA/VEN in newly diagnosed AML with high-risk features is planned for Q1 [----] with European enrollment anticipated in Q2 [----] NEW YORK Jan. [--] [----] (GLOBE NEWSWIRE) -- SELLAS Life Sciences Group Inc. (NASDAQ: SLS) (SELLAS or the Company) a late-stage clinical biopharmaceutical company focused"
News Link @YahooFinance 2026-01-14T14:08Z 2M followers, [---] engagements

Aza